Skip to main content
. 2012 Jul 10;51(34):8529–8533. doi: 10.1002/anie.201203263

Figure 1.

Figure 1

2,2-dilinoleyl-4-dimethylaminoethyl-[1,3]-dioxolane (DLin-KC2-DMA, 1). No difference in activity between enantiomers (4, 5) or the racemic mixture was observed (Table 1).